Endocrine pancreatic tumors, Lu-177-DOTA-octreotate, Neoadjuvant treatment, Neuroendocrine tumors, Peptide receptor radionuclide therapy, Somatostatin receptor targeting
dx.doi.org/10.1097/RLU.0b013e318238f003, hdl.handle.net/1765/83399
Clinical Nuclear Medicine
Department of Nuclear Medicine

Ezziddin, S, Lauschke, H, Schaefers, M, Meyer, C, van Essen, M, Biersack, H.-J, … Ahmadzadehfar, H. (2012). Neoadjuvant downsizing by internal radiation: A case for preoperative peptide receptor radionuclide therapy in patients with pancreatic neuroendocrine tumors. Clinical Nuclear Medicine, 37(1), 102–104. doi:10.1097/RLU.0b013e318238f003